| Year |
Citation |
Score |
| 2018 |
Acuña UM, Mo S, Zi J, Orjala J, DE Blanco EJC. Hapalindole H Induces Apoptosis as an Inhibitor of NF-ĸB and Affects the Intrinsic Mitochondrial Pathway in PC-3 Androgen-insensitive Prostate Cancer Cells. Anticancer Research. 38: 3299-3307. PMID 29848677 DOI: 10.21873/Anticanres.12595 |
0.568 |
|
| 2014 |
Pauli GF, Chen SN, Lankin DC, Bisson J, Case RJ, Chadwick LR, Gödecke T, Inui T, Krunic A, Jaki BU, McAlpine JB, Mo S, Napolitano JG, Orjala J, Lehtivarjo J, et al. Essential parameters for structural analysis and dereplication by (1)H NMR spectroscopy. Journal of Natural Products. 77: 1473-87. PMID 24895010 DOI: 10.1021/Np5002384 |
0.587 |
|
| 2014 |
Muñoz Acuña U, Mo S, Orjala J, Carcache de Blanco E. Hapindole H NF-kappaB inhibitory activity and apoptotic effect on PC-3 prostate cancer cells Planta Medica. 80. DOI: 10.1055/S-0034-1382396 |
0.557 |
|
| 2011 |
Chlipala GE, Mo S, Orjala J. Chemodiversity in freshwater and terrestrial cyanobacteria - a source for drug discovery. Current Drug Targets. 12: 1654-73. PMID 21561419 DOI: 10.2174/138945011798109455 |
0.598 |
|
| 2011 |
Chlipala GE, Krunic A, Mo S, Sturdy M, Orjala J. CYANOS: a data management system for natural product drug discovery efforts using cultured microorganisms. Journal of Chemical Information and Modeling. 51: 171-80. PMID 21162567 DOI: 10.1021/Ci100280A |
0.564 |
|
| 2010 |
Krunic A, Vallat A, Mo S, Lantvit DD, Swanson SM, Orjala J. Scytonemides A and B, cyclic peptides with 20S proteasome inhibitory activity from the cultured cyanobacterium Scytonema hofmanii. Journal of Natural Products. 73: 1927-32. PMID 21058727 DOI: 10.1021/Np100600Z |
0.606 |
|
| 2010 |
Mo S, Krunic A, Santarsiero BD, Franzblau SG, Orjala J. Hapalindole-related alkaloids from the cultured cyanobacterium Fischerella ambigua. Phytochemistry. 71: 2116-23. PMID 20965528 DOI: 10.1016/J.Phytochem.2010.09.004 |
0.611 |
|
| 2009 |
Chlipala G, Mo S, Carcache de Blanco EJ, Ito A, Bazarek S, Orjala J. Investigation of antimicrobial and protease-inhibitory activity from cultured cyanobacteria. Pharmaceutical Biology. 47: 53-60. PMID 21430788 DOI: 10.1080/13880200802415483 |
0.594 |
|
| 2009 |
Mo S, Krunic A, Pegan SD, Franzblau SG, Orjala J. An antimicrobial guanidine-bearing sesterterpene from the cultured cyanobacterium Scytonema sp. Journal of Natural Products. 72: 2043-5. PMID 19888742 DOI: 10.1021/Np900288X |
0.62 |
|
| 2009 |
Guo S, Tipparaju SK, Pegan SD, Wan B, Mo S, Orjala J, Mesecar AD, Franzblau SG, Kozikowski AP. Natural product leads for drug discovery: isolation, synthesis and biological evaluation of 6-cyano-5-methoxyindolo[2,3-a]carbazole based ligands as antibacterial agents. Bioorganic & Medicinal Chemistry. 17: 7126-30. PMID 19783449 DOI: 10.1016/J.Bmc.2009.08.061 |
0.589 |
|
| 2009 |
Mo S, Krunic A, Chlipala G, Orjala J. Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua. Journal of Natural Products. 72: 894-9. PMID 19371071 DOI: 10.1021/Np800751J |
0.618 |
|
| 2008 |
Nichols D, Lewis K, Orjala J, Mo S, Ortenberg R, O'Connor P, Zhao C, Vouros P, Kaeberlein T, Epstein SS. Short peptide induces an "uncultivable" microorganism to grow in vitro. Applied and Environmental Microbiology. 74: 4889-97. PMID 18515474 DOI: 10.1128/Aem.00393-08 |
0.546 |
|
| Show low-probability matches. |